Dapaxifra-M Tablet ER
Marketer
Effra Lifesciences
Salt Composition
Dapagliflozin (10mg) + Metformin (500mg)
Overview Dapaxifra-M Tablet ER
Diabex Duo ER tablets combine two medications to manage type 2 diabetes. This dual-action formulation helps regulate elevated blood glucose, mitigating the risk of severe diabetic complications and potentially preventing cardiovascular issues. Diabex Duo ER can be taken with food; consistent daily dosing improves adherence. Dosage is determined by your physician, and discontinuation should only occur under medical supervision, as abrupt cessation may elevate blood sugar, potentially leading to kidney damage or vision loss. This medication is a component of a comprehensive diabetes management plan that incorporates dietary adjustments, exercise, and weight control as recommended by your doctor. Common side effects include throat irritation, nasal stuffiness, rhinorrhea, headache, nausea, vomiting, and diarrhea. Adequate hydration is recommended to prevent dehydration. Genital fungal infections are a potential side effect; diligent hygiene is crucial for prevention. Prior to commencing treatment, inform your physician of any pre-existing kidney or liver disease, urinary tract infections, or diuretic use. Pregnant or lactating individuals should seek medical counsel before initiating treatment. Limit alcohol consumption while using this medication to minimize the potential for increased side effects. Regular blood glucose monitoring is essential during treatment.
Primary Ingredients of Dapaxifra-M Tablet ER
No text was provided to rewrite.
Uses of Dapaxifra-M Tablet ER
Managing Type 2 Diabetes
Major Benefits of Dapaxifra-M Tablet ER:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. It's recommended to take Dapaxifra-M Extended-Release tablets with food.
Common Side effects of Dapaxifra-M Tablet ER:
- Nausea
- Vomiting
- Diarrhea
- Genital fungal infection
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Urinary tract infection
- Polyuria
- Flatulence
- Skin rash
- Taste change
- Difficulty in urination
- Hypoglycemia (low blood glucose level)
- Tremors
- Dizziness
- Back pain
- Increased hematocrit
- Decreased creatinine clearance
- Dyslipidemia
How to use Dapaxifra-M Tablet ER:
Consume this medication precisely as prescribed by your physician, adhering to both dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It is recommended to take Dapaxifra-M Extended-Release tablets with food.
How Dapaxifra-M Tablet ER works:
Dapaxifra-M Extended-Release tablets combine dapagliflozin and metformin to manage type 2 diabetes. Dapagliflozin eliminates excess glucose via urinary excretion, while metformin reduces hepatic glucose production, slows intestinal glucose uptake, and enhances insulin responsiveness. This dual action improves overall glycemic control.
SAFETY ADVICE
AlcoholUNSAFE
Avoid alcohol while taking Dapaxifra-M Tablet ER; doing so is unsafe.
PregnancyCONSULT YOUR DOCTOR
Extended-release Dapaxifra-M tablets may pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the benefits against potential risks prior to prescription. Physician consultation is advised.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Dapaxifra-M tablets are likely unsafe for breastfeeding mothers. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.
KidneyCAUTION
Extended-release Dapaxifra-M tablets require careful administration for individuals with impaired renal function. Dosage modification of Dapaxifra-M extended-release tablets may be necessary. Physician consultation is advised.
LiverCAUTION
Extended-release Dapaxifra-M tablets require careful administration for individuals with hepatic impairment. Dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Dapaxifra-M Tablet ER :
Should you forget a Dapaxifra-M Tablet ER dose, take it immediately if you remember. However, near the time for your next dose, omit the missed dose and resume your usual schedule. Never take a double dose.
Facts to Know About Dapaxifra-M Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Treatment |



